Thiogenesis Therapeutics Corp's total assets for Q3 2024 were $4.25M, a decrease of -16.01% from the previous quarter. TSE:TTI total liabilities were $105.92K for the fiscal quarter, a -65.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.